Robert Sisk, MD
Ophthalmology · Cincinnati, OHNPI 1063614089
Payments from drug & device makers
Across 263 payments — averaging $3157.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$302K
- Novartis$287K
- AbbVie$150K
- Spark Therapeutics, Inc.$49K
- Eyepoint US, Inc.$19K
- Leica Microsystems Inc.$15K
- plus $10K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 15 | $301,666 |
| Novartis | 9 | $286,761 |
| AbbVie(2 entities) | 51 | $149,796 |
| Spark Therapeutics, Inc. | 13 | $48,678 |
| Eyepoint US, Inc. | 19 | $18,706 |
| Leica Microsystems Inc. | 5 | $15,368 |
| Astellas Pharma US Inc | 15 | $3,119 |
| Apellis Pharmaceuticals, Inc. | 13 | $2,386 |
| Regeneron Healthcare Solutions, Inc. | 44 | $1,267 |
| Genentech USA, Inc. | 38 | $1,125 |
| Alimera Sciences, Inc. | 18 | $458 |
| Alcon | 2 | $247 |
| Regeneron | 1 | $138 |
| Astellas US LLC | 1 | $136 |
| Carl Zeiss Meditec USA, Inc. | 1 | $135 |
| ANI Pharmaceuticals, Inc. | 4 | $118 |
| Samsara Vision | 1 | $115 |
| Bausch & Lomb Americas Inc. | 5 | $93 |
| Biotissue Holdings Inc. | 2 | $57 |
| Notal Vision, Inc. | 1 | $47 |
| Sandoz | 1 | $28 |
| Amgen | 1 | $17 |
| Oyster Point Pharma, Inc. | 1 | $17 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $13 |
| Lumibird Medical Inc. | 1 | $12 |
How this compares
$830,504 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Cincinnati
- Daniel MillerCincinnati$2.3M
- Michael SnyderCincinnati$1.3M
- Christopher RiemannCincinnati$985K
- Anup KhatanaCincinnati$794K
- Robert OsherCincinnati$720K
- Haroon ChaudhryCincinnati$708K
- Christopher DevineCincinnati$623K
- Robert BenzaCincinnati$224K
- Linda GreffCincinnati$168K
- Karen KlugoCincinnati$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.